Before You Start Peptides: A Doctor Answers Your Biggest Questions

Dr. Ashley Froese Answers the Questions Everyone Asks Before Starting Peptides

Dr. Ashley Froese returns with a video specifically designed for people who are interested in peptides but have not taken the step of actually starting them. With 265K views, this FAQ-style video addresses the practical questions that search engines and online forums do not answer well: How do I find a legitimate prescriber? How do I know if a peptide source is safe? What should I expect in the first few weeks? How long does a cycle last? And the big one: is this actually worth it?

Froese structures this as a direct Q&A based on the most common questions she receives from patients and social media followers. The format works well because it mirrors the actual decision-making process people go through. You do not start with the science and work toward practical considerations. You start with practical concerns and work backward toward the science as needed.

Finding a Prescriber Who Knows What They Are Doing

Froese starts with what she considers the most important question. Not "which peptide should I take" but "who should I work with." Peptide therapy is not taught in most medical schools or residency programs. A doctor's general medical knowledge does not automatically translate to competence in peptide prescribing. You need someone who has specifically trained in peptide therapy, ideally through recognized clinical education programs, and who has practical experience prescribing and monitoring peptide protocols.

She suggests looking for practitioners who are members of organizations like the American Academy of Anti-Aging Medicine (A4M) or who have completed specific peptide therapy training. Functional medicine doctors and integrative medicine practitioners are more likely to have peptide experience than conventional primary care physicians. But credentials alone are not sufficient. Ask the practitioner how many peptide patients they manage, which peptides they prescribe most often, and how they monitor treatment.

Red flags include practitioners who prescribe peptides without taking a medical history, who do not require lab work before or during treatment, or who sell their own peptide products at marked-up prices. A good peptide prescriber will work with an independent compounding pharmacy and will not profit from the products they prescribe.

Sourcing: How to Evaluate a Compounding Pharmacy

Froese spends significant time on sourcing because this is where the greatest risk lies for peptide users. Not all compounding pharmacies are equal. The difference between a high-quality pharmacy and a low-quality one can mean the difference between getting a pure, correctly dosed product and getting something contaminated, underdosed, or mislabeled.

She recommends looking for pharmacies that are 503A licensed (producing patient-specific prescriptions) or 503B registered (operating under more stringent manufacturing standards). Either is acceptable, but 503B pharmacies are held to higher production and testing standards. Ask for certificates of analysis (COAs) that show third-party testing for potency, purity, sterility, and endotoxin levels.

Froese is direct about research chemical suppliers: avoid them for therapeutic use. Research chemicals are sold "not for human consumption" and are not subject to the quality standards that compounding pharmacies must meet. The price may be lower, but the risk is not worth the savings when you are injecting something into your body.

What to Expect in the First Few Weeks

Froese walks through realistic timelines for the most popular peptides. BPC-157 users often notice initial effects within the first one to two weeks, typically reduced pain or improved gut symptoms. The full healing benefit usually develops over four to eight weeks. TB-500 follows a similar timeline. Growth hormone secretagogues like ipamorelin may improve sleep quality within the first week but take four to six weeks to show effects on body composition or recovery.

She emphasizes that individual response varies significantly. Some people feel dramatic effects quickly. Others notice gradual, subtle changes. And some do not notice much at all, which does not necessarily mean the peptide is not working. Healing at the tissue level can occur without producing noticeable symptoms, particularly for chronic conditions that develop slowly.

Side effects in the first week are usually mild if present. Injection site reactions (redness, itching, minor swelling) are the most common. Nausea can occur with BPC-157, particularly with oral dosing. Headaches and flushing can occur with PT-141. Froese recommends starting at the lower end of the dose range and increasing gradually, which minimizes initial side effects.

Cycle Length and When to Stop

The question of how long to use peptides is one that does not have a standardized answer. Froese explains the general framework she uses in practice. For acute injuries, she recommends 4 to 8 week cycles of BPC-157 or TB-500, reassessing at the end of each cycle. If improvement is occurring, continue for another cycle. If no improvement is apparent after 8 weeks, reconsider whether the peptide is the right approach for that specific condition.

For chronic conditions or ongoing maintenance, the approach is less defined. Some practitioners recommend cycling: using peptides for 8 to 12 weeks, taking 4 weeks off, then resuming if needed. Others prescribe continuous low-dose protocols for chronic issues. Froese prefers the cycling approach because it allows periodic reassessment and avoids the theoretical concern of receptor desensitization from continuous use.

Growth hormone secretagogues are typically used for longer periods, often 3 to 6 months, because the benefits accumulate slowly. Froese recommends periodic blood work (IGF-1 levels, metabolic panel) to monitor the hormonal response and ensure that growth hormone levels stay within a safe range.

Lab Work and Monitoring

Froese considers baseline lab work non-negotiable before starting peptide therapy. The specific labs depend on which peptide you are using, but a general panel should include: thorough metabolic panel, complete blood count, inflammatory markers (CRP, ESR), hormonal panel (if using growth hormone secretagogues), and any condition-specific markers relevant to why you are using the peptide.

Follow-up labs should be done at 6 to 8 weeks into the first cycle and then periodically during continued use. For growth hormone secretagogues, she checks IGF-1 levels to ensure the growth hormone response is in the desired range. For BPC-157, she tracks inflammatory markers and any condition-specific outcomes.

The lab work serves two purposes. First, it provides objective data on whether the peptide is producing the expected biological effects. Second, it provides a safety net to catch any unexpected changes early. Peptides have favorable safety profiles in general, but monitoring ensures that your individual response is consistent with what is expected.

Is It Worth It?

Froese closes with the question she gets most often. Her answer is nuanced. For specific conditions with strong preclinical evidence (gut issues and soft tissue injuries with BPC-157, tissue recovery with TB-500), she thinks peptides are worth trying after conventional treatments have been inadequate. The cost is reasonable, the safety profile is favorable, and the potential benefit is real even if not guaranteed.

For general wellness, anti-aging, or optimization purposes, she is less enthusiastic. The evidence for peptides as preventive or optimization tools is thinner than for treatment of specific conditions. If you are healthy and have no particular issue to address, the value proposition is harder to justify.

The Smart First Step

Froese's practical recommendation for someone who wants to try peptides: find a qualified practitioner, get your baseline labs, start with one well-researched peptide (she usually recommends BPC-157 as a starting point for most people), use it for a defined cycle with clear goals, assess the results, and then decide whether to continue, switch, or stop. That methodical approach gives you the best chance of a positive outcome and the clearest information about whether peptide therapy works for your specific situation.

Setting Expectations and Avoiding Disappointment

Froese closes with a section about expectations that is perhaps the most important part of the video. The peptide space, driven partly by social media testimonials and biohacker enthusiasm, tends to set expectations higher than the evidence warrants. People come to peptides expecting dramatic, rapid results because that is what the most compelling anecdotes describe. The reality is that responses vary, improvements are often gradual, and not everyone experiences the headline results.

She recommends setting concrete, measurable goals before starting peptide therapy. If you are using BPC-157 for a tendon injury, your goal might be reduced pain by 50 percent on a self-reported scale after 6 weeks. If you are using it for gut issues, your goal might be a specific reduction in symptoms as tracked by a daily log. Having defined success criteria prevents the drift toward "I think it might be doing something" which is neither useful for clinical decision-making nor satisfying for the patient.

If you hit your goals within the expected timeframe, great. If you do not, that is useful information too. It might mean the peptide is not right for your condition, the dose needs adjustment, or the underlying problem requires a different approach entirely. Failing to respond to a peptide is not a personal failure. It is clinical data that guides your next decision. Froese's framework of starting with clear goals, evaluating honestly, and adjusting based on results is the most rational approach to a therapy category where the evidence is still developing.